Examples of using Astrazeneca in English and their translations into Polish
{-}
-
Colloquial
-
Official
-
Medicine
-
Ecclesiastic
-
Ecclesiastic
-
Financial
-
Official/political
-
Programming
-
Computer
Under the terms of the agreement, AstraZeneca will acquire the respiratory business including products Daxas(roflumilast),
By way of example, the Commission sanctioned AstraZeneca for misusing the regulatory system in order to delay market entry of generic drugs competing with its blockbuster product Losec.
which were transmitted to AstraZeneca.
a collaborative project with Pfizer and AstraZeneca to develop a 21st-century interface to biomedical literature and data management.
We're delighted to collaborate with AstraZeneca on this exciting new initiative, which will give leading Cancer Research UK scientists
At AstraZeneca, employees are our greatest asset,
on restrictive practices and dominant positions given at its 391st meeting on 30 may 2005 concerning a Draft Decision in case COMP/A.37.507/B2- AstraZeneca.
AstraZeneca AB Gärtunavtägen, B674:5 SE-151 85 Södertälje Sweden The printed package leaflet
friendly working space.- says Beata Paluchowska, HR Director at AstraZeneca Pharma Poland.
The majority of members of the Advisory Committee agrees with the Commission that AstraZeneca has abused its dominant position by systematic misusing the procedures for the authorisation of pharmaceutical products by selective deregistration of Losec capsules in Denmark,
the Commission adopted a decision fining AstraZeneca AB and AstraZeneca Plc(AZ) EUR 60 million for having infringed Article 82 EC
the Commission adopted a decision fining AstraZeneca AB and AstraZeneca Plc(AZ)
The majority of members of the Advisory Committee agrees with the Commission that AstraZeneca has abused its dominant position by its pattern of misrepresentations which were made over a long period of time to patent offices in Belgium,
AstraZeneca: A British-Swedish multinational pharmaceutical and biologics company headquartered in London.
The European Commission granted a marketing authorisation valid throughout the European Union for Possia to AstraZeneca on 03 December 2010.
AstraZeneca PLC has been fined $520 million in the United States for off-label promotion to doctors for their anti-psychotic drug, Seroquel.
The AstraZeneca companies were in a dominant position in the relevant European(and other)
GlaxoSmithKline, AstraZeneca, Wyeth, Merck,
Furthermore, I ensured that AstraZeneca was provided with all additional non-confidential documents that had been placed on the Commission's case file subsequent to the issuance of the Statement of Objections.
smaller companies capable of marketing this anti-ulcer product were prevented from manufacturing it at a much lower price than the AstraZeneca companies.